Karen Omann Binderup

Title

PhD Fellow

Primary affiliation

Karen Omann Binderup

Areas of expertise

  • Endometrial cancer
  • DNA-methylation
  • Patient-collected urine samples
  • Patient-collected vaginal samples
  • Postmenopausal bleeding

Contact information

Email address

Research

My field of study is DNA methylation as a biomarker for gynecological cancers. My clinical PhD project investigates whether DNA methylation as a biomarker in patient-collected urine and vaginal samples can improve risk assessment for women suspected of having endometrial cancer. The goal is faster and gentler risk stratification, ensuring that high-risk women are promptly referred, while low-risk patients can avoid invasive procedures. This can benefit both patients and the healthcare system

Selected publications

Use arrow keys on your keyboard to explore